Kenneth D'Arigo

Kenneth (Kenny) D'Arigo has a diverse and extensive work experience in the field of biotechnology and pharmaceuticals. Kenneth (Kenny) is currently working as a Scientist in Cell Therapy Development at Turnstone Biologics since October 2021. Prior to this, they worked at Iovance Biotherapeutics, Inc. as a Scientist I from January 2021 to October 2021, and as an Associate Scientist from March 2018 to January 2021. At Iovance Biotherapeutics, they optimized an enzymatic digest protocol for isolation of T cells from tumors, developed a selection process for a more effective TIL product, and evaluated platforms for designing an autologous cell killing assay.

Before joining Iovance Biotherapeutics, Kenneth worked at BPS Bioscience Inc. as a Research Scientist I from April 2017 to March 2018. In this role, they executed a wide range of cell-based assays in the areas of immunotherapy and oncology, engaged with clients to plan experiments, maintained cell cultures, and created recombinant cell lines and assays.

Prior to BPS Bioscience, Kenneth was a Senior Research Associate (Infectious Disease) at NantKwest from October 2016 to March 2017. Kenneth (Kenny)'sresponsibilities included organizing laboratory supplies, engaging with vendors, and conducting basic cell culture.

Kenneth's earlier experience includes working as a Senior Research Associate II at aTyr Pharma from May 2008 to October 2016, as a Research Scientist at Progenics Pharmaceuticals, Inc. from April 2007 to April 2008, as a Research Associate Scientist at Tanox (acquired by Genetech) from August 2005 to April 2007, and as a Research Scientist at Applied Molecular Evolution (acquired by Eli Lilly) from September 2001 to August 2005.

Overall, Kenneth has demonstrated their expertise in cell therapy development, immunotherapy, oncology, and infectious diseases through their various roles in the biotechnology and pharmaceutical industry.

Kenneth (Kenny) D'Arigo completed their Master of Science degree in Cell Biology and Pharmacology from the Medical University of South Carolina from 1994 to 1998.